5773 – Safety and Antiviral Activity of Remdesivir for severe COVID-19 5774 – Safety & Antiviral Activity of Remdesivir for moderate COVID-19 CATALYST – An Early Phase Platform Trial in COVID-19 COPCOV – Chloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; a randomised, placebo-controlled prophylaxis study COVAC – Clinical trial of a SARS-CoV-2 vaccine in healthy men and women COVACTA – A study to evaluate TCZ in patients with severe COVID-19 Pneumonia CCP-UK – Clinical Characterisation Protocol for Severe Emerging Infection COV001 – A phase I/II trial of a candidate COVID-19 vaccine COV002 – Investigating a Vaccine Against COVID-19 DeVENT – Decision support system to evaluate VENTilation in ARDS PRINCIPLE – Platform Randomised trial of INterventions against COVID-19 In older peoPLE RECOVERY – Randomised Evaluation of COVID-19 Therapy RECOVERY-Supportive Care – Ventilation Strategies in COVID-19; CPAP, High-flow, and standard care REMAP-CAP – Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia RUX-COVID – Study to assess the efficacy and safety of ruxolitinib in patients with COVID-19 associated cytokine storm.
